Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,024 | 341 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $916.73 | 40 | $0 (2024) |
| Amgen Inc. | $690.28 | 48 | $0 (2024) |
| Lilly USA, LLC | $599.02 | 32 | $0 (2024) |
| Novo Nordisk Inc | $588.15 | 34 | $0 (2024) |
| PFIZER INC. | $523.24 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $429.00 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $345.05 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $270.07 | 10 | $0 (2024) |
| UCB, Inc. | $201.90 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $201.23 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,013 | 120 | Novartis Pharmaceuticals Corporation ($325.41) |
| 2023 | $2,614 | 148 | Amgen Inc. ($347.76) |
| 2022 | $1,171 | 59 | ABBVIE INC. ($527.65) |
| 2021 | $226.65 | 14 | PFIZER INC. ($60.29) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: PAIN | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: UROLOGY | ||||||
| 12/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: PAIN | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 723 | 799 | $164,464 | $66,726 |
| 2022 | 6 | 772 | 822 | $175,440 | $74,654 |
| 2021 | 3 | 168 | 173 | $37,707 | $17,060 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 346 | 346 | $82,348 | $37,450 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 193 | 243 | $51,759 | $19,037 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 91 | $13,195 | $5,037 | 38.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 82 | 89 | $9,968 | $2,951 | 29.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,936 | $1,638 | 41.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 18 | $3,258 | $613.64 | 18.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 464 | 464 | $110,432 | $51,819 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 222 | $47,286 | $17,012 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 63 | $9,135 | $3,337 | 36.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 39 | 42 | $4,652 | $1,406 | 30.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 19 | $3,371 | $984.06 | 29.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $564.00 | $96.76 | 17.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 86 | 86 | $20,468 | $9,787 | 47.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 68 | $14,484 | $6,077 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 19 | $2,755 | $1,196 | 43.4% |
About Scott Thouvenot
Scott Thouvenot is a Family healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2015. The National Provider Identifier (NPI) number assigned to this provider is 1669844932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scott Thouvenot has received a total of $6,024 in payments from pharmaceutical and medical device companies, with $2,013 received in 2024. These payments were reported across 341 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,024).
As a Medicare-enrolled provider, Thouvenot has provided services to 1,663 Medicare beneficiaries, totaling 1,794 services with total Medicare billing of $158,440. Data is available for 3 years (2021–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Chesterfield, MO
- Active Since 10/27/2015
- Last Updated 10/27/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1669844932
Products in Payments
- TREMFYA (Drug) $345.05
- RINVOQ (Biological) $275.06
- TALTZ (Drug) $271.73
- Otezla (Drug) $263.19
- MOUNJARO (Drug) $255.00
- SKYRIZI (Biological) $248.16
- QULIPTA (Drug) $219.63
- Ozempic (Drug) $213.47
- ELIQUIS (Drug) $205.92
- LEQVIO (Drug) $196.65
- TAVNEOS (Drug) $194.48
- Rybelsus (Drug) $184.95
- Cimzia (Drug) $180.73
- Cologuard Collection Kit (Device) $156.32
- SHINGRIX (Biological) $152.72
- NURTEC ODT (Drug) $149.71
- COSENTYX (Drug) $136.68
- Enbrel (Biological) $117.73
- GEMTESA (Drug) $117.01
- Wegovy (Drug) $99.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Chesterfield
Jared Hu, Fnp-Bc, FNP-BC
Family — Payments: $20,726
Whitney Feichtner, Fnp, FNP
Family — Payments: $15,487
Jessica Kemp
Family — Payments: $10,518
Christine Mathews, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $7,177
Hannah Powers
Family — Payments: $3,610
Brandy Binger, Fnp-Bc, FNP-BC
Family — Payments: $3,035